57 related articles for article (PubMed ID: 9002758)
21. Biodistribution of [111In-DTPA-D-Phe1]-octreotide in dogs: uptake in the stomach and intestines but not in the spleen points towards interspecies differences.
Robben J; Claude Reubi J; Pollak Y; Voorhout G
Nucl Med Biol; 2003 Apr; 30(3):225-32. PubMed ID: 12745013
[TBL] [Abstract][Full Text] [Related]
22. Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
Tolmachev V; Orlova A; Wei Q; Bruskin A; Carlsson J; Gedda L
Cancer Biother Radiopharm; 2004 Aug; 19(4):491-501. PubMed ID: 15453964
[TBL] [Abstract][Full Text] [Related]
23. Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration.
Bernhardt P; Kölby L; Johanson V; Nilsson O; Ahlman H; Forssell-Aronsson E
Nucl Med Biol; 2003 Apr; 30(3):253-60. PubMed ID: 12745016
[TBL] [Abstract][Full Text] [Related]
24. Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs.
Hosono M; Hosono MN; Haberberger T; Zamora PO; Guhlke S; Bender H; Knapp FF; Biersack HJ
Jpn J Cancer Res; 1996 Sep; 87(9):995-1000. PubMed ID: 8878464
[TBL] [Abstract][Full Text] [Related]
25. Effect of carboxylation of N-terminal phenylalanine of (111)in-DTPA (diethylenetriaminepentaacetic acid)-octreotide on accumulation of radioactivity in kidney.
Akizawa H; Takimoto H; Saito M; Iwado A; Mifune M; Saito Y; Uehara T; Arano Y; Mukai T; Hanaoka H; Saji H
Biol Pharm Bull; 2004 Feb; 27(2):271-2. PubMed ID: 14758051
[TBL] [Abstract][Full Text] [Related]
26. 114mIn, a candidate for radionuclide therapy: low-energy cyclotron production and labeling of DTPA-D-phe-octreotide.
Tolmachev V; Bernhardt P; Forssell-Aronsson E; Lundqvist H
Nucl Med Biol; 2000 Feb; 27(2):183-8. PubMed ID: 10773548
[TBL] [Abstract][Full Text] [Related]
27. Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides.
Akizawa H; Arano Y; Mifune M; Iwado A; Saito Y; Mukai T; Uehara T; Ono M; Fujioka Y; Ogawa K; Kiso Y; Saji H
Nucl Med Biol; 2001 Oct; 28(7):761-8. PubMed ID: 11578896
[TBL] [Abstract][Full Text] [Related]
28. Redesign of negatively charged
Oshima N; Akizawa H; Kawashima H; Zhao S; Zhao Y; Nishijima KI; Kitamura Y; Arano Y; Kuge Y; Ohkura K
Nucl Med Biol; 2017 May; 48():16-25. PubMed ID: 28160666
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of three gamma detectors for intraoperative detection of tumors using 111In-labeled radiopharmaceuticals.
Benjegård SA; Sauret V; Bernhardt P; Wängberg B; Ahlman H; Forssell-Aronsson E
J Nucl Med; 1999 Dec; 40(12):2094-101. PubMed ID: 10616891
[TBL] [Abstract][Full Text] [Related]
30. A typical (111)In-diaethylenotriamino pentaacetic acid-octreotide and (99m)Tc-(V)-dimercapto succinic acid uptake patterns, after radiation treatment.
Bozkurt MF; Ergun EL
Hell J Nucl Med; 2008; 11(2):127-9. PubMed ID: 18815676
[No Abstract] [Full Text] [Related]
31. [Phase I clinical study for 111In-DTPA-IgG].
Kubo A; Nakamura K; Hashimoto J; Hashimoto T; Sammiya T; Shimizu S; Shimada K
Kaku Igaku; 1994 Sep; 31(9):1121-31. PubMed ID: 7967198
[TBL] [Abstract][Full Text] [Related]
32. Characterization of (111)In(3+) complexes of DTPA amide derivatives: biodistribution and clearance studied by gamma imaging.
Prata MI; Santos AC; Bligh SW; Chowdhury AH; Geraldes CF; de Lima JJ
Nucl Med Biol; 2000 Aug; 27(6):605-10. PubMed ID: 11056377
[TBL] [Abstract][Full Text] [Related]
33. Biodistribution and pharmacokinetics of 111In-dTPA-labelled pegylated liposomes after intraperitoneal injection.
Syrigos KN; Vile RG; Peters AM; Harrington KJ
Acta Oncol; 2003; 42(2):147-53. PubMed ID: 12801133
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity Analysis of a Physiologically Based Pharmacokinetic Model Used for Treatment Planning in Peptide Receptor Radionuclide Therapy.
Hardiansyah D; Begum NJ; Kletting P; Mottaghy FM; Glatting G
Cancer Biother Radiopharm; 2016 Aug; 31(6):217-24. PubMed ID: 27403777
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of receptor targeted 111In-DTPA-glycoproteins: identification of 111In-DTPA-epsilon-lysine as the primary metabolic and excretory product.
Franano FN; Edwards WB; Welch MJ; Duncan JR
Nucl Med Biol; 1994 Nov; 21(8):1023-34. PubMed ID: 9234360
[TBL] [Abstract][Full Text] [Related]
36. Rapid transit of tracer to the kidneys and urinary bladder in radionuclide cisternography. A sign of CSF leak.
Halkar R; Pettigrew R; Lipman C; Gilles L
Clin Nucl Med; 1997 Feb; 22(2):121-3. PubMed ID: 9031773
[No Abstract] [Full Text] [Related]
37. Nonlinear compartmental model of 18F-choline.
Tavola F; Janzen T; Giussani A; Facchinetti D; Veronese I; Uusijärvi-Lizana H; Mattsson S; Hoeschen C; Cantone MC
Nucl Med Biol; 2012 Feb; 39(2):261-8. PubMed ID: 22136887
[TBL] [Abstract][Full Text] [Related]
38. A control systems approach for the simulation of renal dynamic software phantoms for nuclear medicine.
Houston AS; Sampson WF; Jose RM; Boyce JF
Phys Med Biol; 1999 Feb; 44(2):401-11. PubMed ID: 10070790
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of 111In-labeled bleomycin in patients with brain tumors: compartmental vs. non-compartmental models.
Ryynänen PM; Savolainen SE; Aronen HJ; Korppi-Tommola ET; Huhmar HM; Kallio ME; Hiltunen JV
Ann Nucl Med; 1998 Dec; 12(6):313-21. PubMed ID: 9972368
[TBL] [Abstract][Full Text] [Related]
40. Influence of endogenous biotin on the biodistribution of labelled biotin derivatives in mice.
Rusckowski M; Fogarasi M; Virzi F; Hnatowich DJ
Nucl Med Commun; 1995 Jan; 16(1):38-46. PubMed ID: 7609933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
